Prediabetes
Prediabetes is an early stage of diabetes characterized by elevated blood glucose levels that are not yet high enough to be classified as diabetes, often associated with obesity, dyslipidemia, and hypertension, and it significantly increases the risk of developing type 2 diabetes and cardiovascular disease. Effective management largely involves lifestyle interventions aimed at weight loss.
Health Outcomes
- Atherogenic Lipid Profile
- Characterized Carbohydrate Metabolism Enzyme Activity
- Decreased Uncarboxylated to Total Osteocalcin Ratio
- Diabetes Progression
- Distinct Metabolic Profile
- Elevated Insulin Levels
- Enhanced Carbohydrate Oxidation
- Enhanced GLP-1 Secretion
- Enhanced Insulin Secretion
- Improved Acid Buffering Capacity
- Improved Adipokine Profile
- Improved Atherogenic Index of Plasma
- Improved Atherosclerosis-Related Cardiovascular Risk Markers
- Improved Beta-Cell Function
- Improved Bioactivity
- Improved Biochemical Change
- Improved Blood Biochemical Parameter
- Improved Blood Biomarker Level
- Improved Blood Clinical Chemistry
- Improved Blood Glucose Concentration
- Improved Blood Glucose Control
- Improved Blood Glucose Levels
- Improved Blood Lipid Profile
- Improved Carbohydrate Metabolism
- Improved Cardio-Metabolic Profile
- Improved Cardiometabolic Health
- Improved Cardiometabolic Score
- Improved DASH Score
- Improved Diet
- Improved Diet Quality
- Improved Diet Quality Index
- Improved Endocrine Function
- Improved Fasting Glucose Levels
- Improved Fasting Plasma Glucose
- Improved Gastrointestinal Hormone Regulation
- Improved Glucose Homeostasis
- Improved Glucose Level
- Improved Glucose Metabolism
- Improved Glucose Regulation
- Improved Glucose Response
- Improved Glucose Tolerance
- Improved Glycemia
- Improved Glycemic Control
- Improved Glycemic Response
- Improved Glycogen Synthetase Activity
- Improved HOMA-B
- Improved HbA1c
- Improved Hemoglobin A1c Levels
- Improved High-Intensity Intermittent Exercise Performance
- Improved Hormonal Counter-Regulation
- Improved Incretin Release
- Improved Insulin Levels
- Improved Insulin Resistance
- Improved Insulin Response
- Improved Insulin Secretion
- Improved Insulin Secretion Rate
- Improved Insulin Sensitivity
- Improved Life's Essential 8 Score
- Improved Maternal Metabolic Health
- Improved Metabolic Health
- Improved Metabolic Homeostasis
- Improved Metabolic Indicator
- Improved Metabolic Marker
- Improved Metabolic Parameters
- Improved Metabolic Profile
- Improved Metabolic Regulation
- Improved Metabolic Syndrome Remission
- Improved Metabolomic Profile
- Improved Normal Glucose Tolerance Conversion Rate
- Improved Plasma Glucose Control
- Improved Postprandial Glucose Levels
- Improved Protein Secretion
- Improved SHBG Level
- Improved Satiety Hormonal Status
- Improved Satiety Index
- Improved Serum Glucose Levels
- Improved Serum Glycemia
- Improved Substrate Utilization
- Improved Systemic Health
- Improved Time in Range
- Improved VLDL Cholesterol
- Improved Weight Loss
- Improved Weight Management
- Increased Adipose Browning
- Increased Bioactivity
- Increased Blood Glucose Levels
- Increased Branched Chain Amino Acid Levels
- Increased C-Peptide Secretion
- Increased C-peptide Level
- Increased Dietary Fiber Intake
- Increased Fasting Insulin Level
- Increased GLP-1 Levels
- Increased Glucagon Level
- Increased Glucagon-Like Peptide 1 Level
- Increased Glucose Uptake
- Increased Glucose Uptake by Cells
- Increased Gut Hormone Level
- Increased Insulin Level
- Increased Insulin Resistance Level
- Increased Insulin Response
- Increased Insulin Secretion
- Increased Milk Alpha-Carotene Concentration
- Increased Plasma Glucagon Level
- Increased Proportion with Normalized Hemoglobin A1c
- Increased Resistant Starch
- Increased Reversion to Normoglycemia
- Increased Serum Glucose Levels
- Increased Serum Insulin Level
- Increased Serum Insulin Levels
- Increased Time in Range
- Increased Triglyceride Level
- Increased Weight Velocity
- Increased β-Cell Area in Pancreatic Islets
- Lower Plasma Glucose Levels
- Maintained Glucose Control
- Modified Serum Metabolomic Pathways
- Multiple Health-Promoting Effects
- No Change in Body Weight or Cardiometabolic Parameters
- No Change in Body Weight or Food Consumption
- No Change in Metabolic Health
- Preserved Pancreatic Beta-Cell Function
- Prevented Metabolic Syndrome
- Prevented Type 2 Diabetes
- Prevention of Obesity Transition
- Prevention of Weight Gain
- Reduced 2-Hour Post-OGTT Glucose Level
- Reduced 2-Hour Postprandial Blood Glucose
- Reduced Adipocyte Senescence
- Reduced Beta Cell Function
- Reduced Beta-Cell Loss
- Reduced Blood Glucose Elevation
- Reduced C-Peptide Level
- Reduced Cardiovascular Disease Risk
- Reduced Cardiovascular Risk Profile
- Reduced Diabetes Incidence
- Reduced Diabetes Mellitus Development
- Reduced Dipeptidyl Peptidase-4 Activity
- Reduced Exercise-Induced Glucose Levels
- Reduced Fasting Blood Glucose
- Reduced Fasting Blood Glucose Level
- Reduced Fasting Blood Glucose Levels
- Reduced Fasting Blood Sugar Levels
- Reduced Fasting Insulin Level
- Reduced Fat Gain
- Reduced First Phase Insulin Secretion
- Reduced GIP
- Reduced Gestational Diabetes
- Reduced Glicentin Level
- Reduced Glucagon-like Peptide-1 Level
- Reduced Glucose Area Under the Curve
- Reduced Glucose Intolerance
- Reduced Glucose Levels
- Reduced Glucose Tolerance
- Reduced Glucose Uptake
- Reduced Glucose-Dependent Insulinotropic Polypeptide Level
- Reduced Glucotoxicity
- Reduced Glycaemic Index
- Reduced Glycated Hemoglobin
- Reduced Glycated Hemoglobin A1c Level
- Reduced Glycated Hemoglobin Level
- Reduced Glycation End Product Accumulation
- Reduced Glycative Stress Marker Level
- Reduced Glycemic Control
- Reduced Glycemic Enzyme Inhibition
- Reduced Glycemic Index
- Reduced Glycemic Parameter
- Reduced Glycemic Response
- Reduced Glycemic Variability
- Reduced Glycosuria
- Reduced Glycosylated Hemoglobin
- Reduced HOMA-B
- Reduced HOMA-IR
- Reduced HOMA-β
- Reduced HbA1c Level
- Reduced Hemoglobin A1c
- Reduced Hepatic Insulin Resistance
- Reduced Homeostasis Model Assessment Index
- Reduced Homeostatic Model Assessment for Insulin Resistance
- Reduced Homeostatic Model Assessment-Insulin Resistance Index
- Reduced Hyperglycemic Response
- Reduced Incidence of Type 2 Diabetes
- Reduced Insulin Output (90-min)
- Reduced Insulin Resistance
- Reduced Insulin Response
- Reduced Insulin Sensitivity
- Reduced Islet β-Cell Dysfunction
- Reduced Metabolic Disease Risk
- Reduced Metabolic Dysregulation
- Reduced Metabolic Endotoxemia
- Reduced Metabolic Syndrome Prevalence
- Reduced Metabolic Syndrome Risk
- Reduced Non-Communicable Disease Risk
- Reduced Pancreatic Stress-Related Pathways
- Reduced Peak Plasma Glucose Level
- Reduced Peak Postprandial Glucose
- Reduced Pharmacological Therapy Requirement
- Reduced Plasma Glucose Levels
- Reduced Post-Exercise Energy Intake
- Reduced Post-Exercise Serum Amyloid A Increase
- Reduced Postprandial Blood Glucose
- Reduced Postprandial Blood Glucose Level
- Reduced Postprandial GLP-1 Level
- Reduced Postprandial Glucagon Level
- Reduced Postprandial Glucose
- Reduced Postprandial Glucose Level
- Reduced Postprandial Glycemia
- Reduced Postprandial Glycemic Response
- Reduced Postprandial Insulin
- Reduced Postprandial Insulin Response
- Reduced Postprandial Triacylglycerol Response
- Reduced Postprandial Triglyceride Level
- Reduced Prevalence of Gestational Diabetes Mellitus
- Reduced Progression to Hypertension
- Reduced Protein Glycation
- Reduced Rapidly Digestible Starch
- Reduced Risk of Diabetes
- Reduced Risk of Type 2 Diabetes
- Reduced Sagittal Abdominal Diameter
- Reduced Sugar Craving
- Reduced Sugar-Sweetened Beverage Intake
- Reduced Systemic Endotoxemia at Rest
- Reduced Triglyceride Glucose Index
- Reduced Two-Hour Postprandial Glucose
- Reduced Type 2 Diabetes Mellitus Incidence
- Reduced Type 2 Diabetes Symptoms
- Reduced Type II Diabetes Mellitus Incidence
- Reduced Ultraprocessed Food Consumption
- Reduced Undercarboxylated-to-Carboxylated Osteocalcin Ratio
- Reduced α-Glucosidase Activity
- Regulated Blood Glucose Levels
- Remission of Metabolic Syndrome
- Reversed Microbiome Metabolic Changes
- Stabilized Blood Glucose Level
- Stabilized Hemoglobin A1c Level
- Stable Antihyperglycemic Effect
- Stable Fasting Blood Sugar Level
- Stable Fasting Plasma Glucose
- Stable Glucose Metabolism Markers
- Unchanged Glycemic Control
- Unchanged Insulin Resistance